PharmaResearch Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	204,368	175,663	165,348	67,245	72,931	41,674
Short-Term Investments	330,800	326,108	230,480	56,549	67,989	2,000
Trading Asset Securities	95,607	112,601	41,523	36,505	43,423	113,123
Cash & Short-Term Investments	630,775	614,372	437,351	160,298	184,343	156,798
Cash Growth	37.55%	40.48%	172.84%	-13.04%	17.57%	97.81%
Accounts Receivable	46,379	44,490	38,459	31,400	32,304	27,741
Other Receivables	5,309	7,312	4,052	3,301	2,757	975.32
Receivables	57,020	57,261	56,564	35,998	36,234	30,490
Inventory	86,661	82,702	57,325	50,232	24,453	17,342
Prepaid Expenses	3,994	1,007	950.54	1,191	667.94	701.54
Other Current Assets	9,509	4,201	2,351	8,746	1,647	1,460
Total Current Assets	787,960	759,542	554,542	256,465	247,345	206,792
Property, Plant & Equipment	180,684	174,549	147,313	123,061	117,960	109,481
Long-Term Investments	55,948	46,260	85,811	99,107	40,718	44,911
Goodwill	12,462	12,462	13,856	11,652	13,810	16,764
Other Intangible Assets	17,724	18,062	18,309	18,821	22,720	24,825
Long-Term Deferred Tax Assets	5,802	7,079	8,557	4,476	8,667	3,166
Long-Term Deferred Charges	709.1	926.33	1,227	1,502	1,297	1,200
Other Long-Term Assets	19,832	19,980	23,745	16,259	21,105	15,715
Total Assets	1,085,373	1,043,888	855,701	535,281	478,055	427,647
Accounts Payable	13,506	11,479	11,081	2,831	3,527	2,939
Accrued Expenses	-	-	-	974.34	860.08	702.95
Short-Term Debt	5,770	7,968	9,359	32,345	18,867	18,873
Current Portion of Long-Term Debt	50.75	42.44	20	33.3	87.4	726.52
Current Portion of Leases	1,339	1,625	2,421	628.25	1,620	1,161
Current Income Taxes Payable	36,475	35,830	23,355	11,357	10,136	6,851
Current Unearned Revenue	-	-	7.89	27.69	11.36	-
Other Current Liabilities	80,621	52,857	35,893	17,703	19,144	16,751
Total Current Liabilities	137,762	109,801	82,137	65,899	54,253	48,005
Long-Term Debt	204,938	202,940	195,865	970.72	45,359	43,385
Long-Term Leases	1,652	425.55	1,121	329.91	835.48	1,466
Pension & Post-Retirement Benefits	2,298	2,437	1,816	1,181	562.74	743.68
Long-Term Deferred Tax Liabilities	1,315	1,479	2,156	2,794	3,741	4,514
Other Long-Term Liabilities	4,242	2,255	2,485	1,911	1,648	1,175
Total Liabilities	352,207	319,338	285,580	73,087	106,399	99,288
Common Stock	5,255	5,255	5,255	5,160	5,056	5,056
Additional Paid-In Capital	193,566	193,566	197,312	175,428	157,582	152,413
Retained Earnings	498,903	492,071	343,061	260,787	190,862	154,018
Treasury Stock	-	-	-4,638	-4,638	-5,260	-5,260
Comprehensive Income & Other	-824.25	-1,561	-1,588	-3,633	-4,737	-785.15
Total Common Equity	696,900	689,331	539,402	433,104	343,503	305,442
Minority Interest	35,576	34,546	30,038	29,091	28,153	22,917
Shareholders' Equity	733,166	724,550	570,121	462,195	371,656	328,359
Total Liabilities & Equity	1,085,373	1,043,888	855,701	535,281	478,055	427,647
Total Debt	213,750	213,001	208,786	34,307	66,768	65,611
Net Cash (Debt)	417,025	401,371	228,565	125,991	117,575	91,187
Net Cash Growth	68.21%	75.60%	81.41%	7.16%	28.94%	94.61%
Net Cash Per Share	35901.52	34704.78	22202.30	11932.17	11785.88	9070.92
Filing Date Shares Outstanding	10.39	10.39	10.39	10.2	9.98	9.98
Total Common Shares Outstanding	10.39	10.39	10.39	10.2	9.98	9.98
Working Capital	650,198	649,741	472,405	190,566	193,092	158,787
Book Value Per Share	67076.29	66347.89	51917.28	42459.18	34433.24	30617.96
Tangible Book Value	666,714	658,807	507,238	402,631	306,974	263,854
Tangible Book Value Per Share	64170.90	63409.96	48821.45	39471.79	30771.48	26449.11
Land	28,782	28,782	21,051	18,617	18,617	14,064
Buildings	82,175	81,918	79,470	81,472	80,151	52,235
Machinery	63,370	60,015	52,305	41,375	30,766	27,162
Construction In Progress	54,647	50,674	31,510	12,459	12,200	32,985